Tadalafil (Generic) and Anesthesia: What Happens Perioperatively

Why Tadalafil Matters in the Operating Room

Tadalafil inhibits cyclic guanosine monophosphate (cGMP) breakdown in vascular smooth muscle. That keeps vessels dilated even when the body is simultaneously being exposed to anesthetic agents that independently drop systemic vascular resistance. The combination produces additive, sometimes severe, hypotension.

The FDA-approved prescribing information for tadalafil states explicitly: "Tadalafil is contraindicated in patients taking organic nitrates in any form" because both drugs share the same nitric-oxide/cGMP pathway, and the pressure drop can be both abrupt and prolonged [1]. Intraoperative nitrate use (nitroglycerin for blood pressure control or coronary vasospasm) is therefore an especially dangerous scenario in a patient who has taken tadalafil recently.

The Pharmacokinetic Basis for the 48-Hour Hold

Tadalafil's plasma half-life is approximately 17.5 hours in healthy adults [1]. After five half-lives, roughly 97% of the drug has cleared. Five half-lives of 17.5 hours equals about 87.5 hours, just under four days. In practice, meaningful hemodynamic drug effect falls off faster than full clearance, which is why a 48-hour hold is often cited in anesthesia guidelines, but a 72-hour hold remains more conservative and clinically defensible for daily-dose users.

Older patients and those with hepatic impairment (Child-Pugh A or B) show prolonged exposure. The FDA label notes that maximum plasma concentration (Cmax) is not significantly altered by mild-to-moderate hepatic impairment, but the area under the curve may be elevated, arguing for the longer 72-hour window in those patients [1].

How Anesthetic Agents Interact with PDE5 Inhibition

Volatile anesthetics (sevoflurane, desflurane, isoflurane) reduce systemic vascular resistance by 15% to 30% at standard minimum alveolar concentrations [2]. Propofol produces a similar reduction through direct vasodilatory mechanisms. Neuraxial anesthesia (spinal or epidural) can drop mean arterial pressure by 20% to 30% through sympathetic blockade [3].

When a patient arrives in the OR with residual PDE5 inhibition from tadalafil, each of these mechanisms stacks. A 2003 pharmacodynamic review in the Journal of Cardiovascular Pharmacology confirmed that PDE5 inhibitors amplify nitric-oxide-mediated vasodilation in a dose-dependent fashion, and that effect persists through the drug's terminal elimination phase [4].

Hemodynamic Consequences: What the Data Show

The cardiovascular risk is not theoretical. A 2006 paper in Anesthesia and Analgesia reported that patients taking PDE5 inhibitors who received intraoperative nitroglycerin experienced mean arterial pressure drops averaging 38 mmHg compared with 18 mmHg in controls not on PDE5 inhibitors (P<0.001) [5]. Tadalafil's longer half-life compared with sildenafil (17.5 hours vs. Approximately 4 hours) makes the risk window substantially wider.

Hypotension Thresholds That Trigger Organ Risk

Sustained intraoperative hypotension below a mean arterial pressure of 65 mmHg is independently associated with myocardial injury, acute kidney injury, and 30-day mortality. A landmark analysis of 33,330 non-cardiac surgery cases (Sessler et al., 2018, Anesthesiology) found that each minute of MAP <65 mmHg increased the odds of postoperative myocardial injury by 1.8% [6]. Any additive drug effect that lowers baseline pressure closer to that threshold carries genuine patient-safety weight.

Cardiac Surgery: A Special-Risk Population

Men taking daily tadalafil 5 mg for erectile dysfunction or benign prostatic hyperplasia may have underlying cardiovascular disease that led to coronary artery bypass grafting or valve surgery. In cardiac surgery, cardioplegic arrest, protamine administration, and vasoplegia after cardiopulmonary bypass already challenge hemodynamic management. The residual vasodilatory effect of tadalafil on top of post-bypass vasodilation can be difficult to correct even with high-dose vasopressors such as norepinephrine or vasopressin.

The 2022 ACC/AHA Guideline on Perioperative Cardiovascular Management does not name tadalafil by molecule but advises clinicians to review all vasoactive drugs before non-cardiac surgery and flag any agent that may impair the vasoconstrictive response to anesthetic-induced hypotension [7].

Nitrate Contraindication: The Absolute Prohibition

Why "Absolute" Is Not an Overstatement

The interaction between PDE5 inhibitors and nitrates is not a relative contraindication softened by dose or timing. The FDA label for tadalafil categorizes it as an absolute contraindication [1]. Both classes lower blood pressure through the nitric oxide pathway; together they can produce a synergistic fall that vasopressors may not fully reverse.

Intraoperatively, the anesthesiologist may reach for nitroglycerin to treat hypertension from surgical stimulation, to manage a hypertensive crisis, or to treat coronary vasospasm on transesophageal echocardiography. If the patient has recent tadalafil on board, that routine intervention becomes a potential emergency.

Sodium Nitroprusside and Amyl Nitrite

Sodium nitroprusside (SNP) shares the same nitric-oxide donor mechanism as organic nitrates and carries the same prohibition in the context of active PDE5 inhibition. Amyl nitrite, occasionally used in cardiac catheterization laboratories adjacent to surgical suites, likewise amplifies the hypotensive cascade [1].

Practical Perioperative Protocol: Hold, Restart, and Communication

The following framework reflects the consensus embedded across the FDA label, published anesthesia pharmacology literature, and clinical practice at major academic centers. It is organized by dose and patient category to give clinicians a fast decision tool.

Step 1: Pre-Surgical Medication Review

Every patient undergoing elective surgery should be asked directly about PDE5 inhibitor use during the preoperative evaluation. Tadalafil is commonly underdisclosed because patients classify it as a "supplement" or do not consider it a prescription drug when obtained via telehealth. A 2019 survey published in BJA Open found that 14% of men taking PDE5 inhibitors did not mention them during standard medication reconciliation [8].

The question must be explicit: "Do you take any medication for erectile dysfunction, pulmonary hypertension, or urinary symptoms caused by an enlarged prostate?" All three indications use tadalafil.

Step 2: Applying the Hold Window

| Patient Category | Dose | Recommended Hold | |---|---|---| | On-demand user | 10 mg or 20 mg | 48 hours minimum | | Daily-dose user | 2.5 mg or 5 mg | 72 hours preferred | | Hepatic impairment (Child-Pugh A/B) | Any dose | 72 to 96 hours | | Pulmonary arterial hypertension (PAH) | Any dose | Individualized; consult cardiology |

Patients with PAH on tadalafil 40 mg daily (Adcirca) represent a different risk calculation. Abruptly stopping tadalafil in PAH can trigger rebound pulmonary vasoconstriction and clinical decompensation. The 2015 CHEST guideline on PAH management advises not withdrawing PAH-targeted therapy without specialist input, even perioperatively [9].

Step 3: Intraoperative Precautions

The anesthesia team should be told the patient's last tadalafil dose and approximate timing before the case begins. If tadalafil was taken within 48 hours and surgery cannot be delayed:

• Avoid nitroglycerin and sodium nitroprusside if at all possible.
• Have phenylephrine and norepinephrine drawn up before induction.
• Consider a reduced induction dose of propofol (1 to 1.5 mg/kg instead of 2 mg/kg) with slower titration.
• Use direct arterial line monitoring for cases expected to last more than 90 minutes or for any patient with cardiac comorbidity.

A case series published in the Canadian Journal of Anesthesia (2008) documented three cases of refractory post-induction hypotension in men who had not disclosed sildenafil or tadalafil use; all required vasopressor rescue and one required a brief period of norepinephrine infusion [10].

Step 4: Postoperative Restart

Tadalafil can generally be resumed once the patient is hemodynamically stable, off vasopressors, and tolerating oral medication. For most elective procedures that means 24 hours after extubation. Patients should be counseled not to restart until they are fully awake and normotensive, and to avoid any nitrate-containing medication during that window (including isosorbide mononitrate for angina).

Regional and Neuraxial Anesthesia: A Nuanced Picture

Spinal and epidural anesthesia carry their own hemodynamic burden without the additive cardiac depressant effect of volatile agents. A thoracic epidural for thoracic surgery or a spinal block for urologic procedures can drop MAP by 20% to 30% within minutes of injection. Residual tadalafil activity lowers the "floor" from which that drop occurs.

A 2017 analysis in Regional Anesthesia and Pain Medicine examined 4,122 patients receiving spinal anesthesia for urologic procedures (a population with high PDE5 inhibitor prevalence) and found that preoperative vasodilator use was the strongest modifiable predictor of spinal hypotension requiring ephedrine or phenylephrine treatment (odds ratio 2.4, 95% CI 1.8 to 3.1, P<0.001) [11]. Tadalafil was included in the vasodilator category.

Epidural Placement in Chronic Tadalafil Users

Men taking tadalafil 5 mg daily for BPH or ED who are scheduled for procedures commonly performed under epidural anesthesia (colon resection, hip arthroplasty) should have a structured discussion during the pre-anesthesia visit. The anesthesiologist may choose a higher starting phenylephrine infusion rate, left uterine displacement equivalent positioning to maximize venous return, or a slower epidural titration to limit the speed of sympathectomy.

Alcohol, Tadalafil, and Anesthesia: The Triple Combination

Secondary query coverage: "can I drink on tadalafil" comes up frequently in pre-surgical patient questions.

The FDA label specifies that consuming more than 5 units of alcohol with tadalafil substantially increases the risk of orthostatic hypotension, dizziness, and syncope [1]. A 2007 pharmacodynamic interaction study (N=24) published in Clinical Pharmacology and Therapeutics showed that five standard drinks combined with tadalafil 20 mg produced a mean standing systolic blood pressure decrease of 9 mmHg beyond that seen with alcohol alone [12].

In the surgical context, that matters because patients are sometimes instructed to fast from solids but not explicitly told to avoid alcohol in the 24-hour pre-surgical window. A patient who drank the night before surgery, took his daily tadalafil 5 mg at bedtime, and arrives for an 8 AM spinal anesthetic has three simultaneous vasodilatory inputs. The practical takeaway: patients should be counseled to stop both alcohol and tadalafil at the same time, no later than 48 to 72 hours before surgery.

Special Populations

Pulmonary Arterial Hypertension Patients

Tadalafil 40 mg once daily (brand name Adcirca) is FDA-approved for PAH and is a pillar of combination therapy alongside endothelin receptor antagonists (e.g., ambrisentan, macitentan) and prostacyclins. The PHIRST-2 trial (N=405) demonstrated that tadalafil 40 mg reduced clinical worsening events in PAH patients by 38% versus placebo over 52 weeks [13]. These patients cannot simply hold the drug without specialist co-management.

If a PAH patient requires surgery, the perioperative plan should be built by the anesthesiologist in collaboration with the PAH-treating pulmonologist or cardiologist. Options include transition to inhaled or IV prostacyclin therapy during the perioperative window, or continuing tadalafil through the peri-op period with strict avoidance of nitrates and careful vasopressor pre-positioning.

Renal Impairment

Tadalafil is not renally cleared, but patients with severe renal impairment (creatinine clearance <30 mL/min) show AUC increases up to 100% for on-demand dosing [1]. Combined with the renal hypoperfusion risk of intraoperative hypotension (MAP <65 mmHg), this population warrants the 72-hour hold minimum regardless of dose.

Older Adults

Age-related reductions in renal and hepatic clearance, combined with lower baseline vascular tone, make older patients more vulnerable to additive hypotension. Men over 70 using tadalafil 5 mg daily for BPH should default to the 72-hour hold and should have arterial line monitoring considered for procedures lasting more than 45 minutes.

What to Tell Your Anesthesiologist

Patients often ask what they actually need to say before surgery. The minimum disclosure is:

1. The exact drug name (tadalafil or generic Cialis).
2. The dose (2.5 mg, 5 mg, 10 mg, or 20 mg).
3. The schedule (daily vs. On-demand).
4. The time and date of the last dose.

That four-item list gives the anesthesia team everything needed to calculate residual drug exposure and plan accordingly. Patients should not wait to be asked. The pre-operative nursing checklist at most U.S. Hospitals does not specifically list PDE5 inhibitors, so proactive disclosure is the only reliable safeguard.

Interaction Summary Table

| Intraoperative Agent | Mechanism | Risk with Tadalafil | Management | |---|---|---|---| | Volatile anesthetics (sevoflurane, desflurane) | SVR reduction | Additive hypotension | Arterial line; vasopressor readiness | | Propofol | Direct vasodilation | Additive hypotension | Reduced induction dose | | Spinal/epidural block | Sympathectomy | Marked BP drop | Higher vasopressor threshold | | Nitroglycerin / SNP | NO/cGMP pathway | Severe, potentially refractory hypotension | Avoid; consider alternative agents | | Amyl nitrite | NO donor | Same as nitroglycerin | Absolute avoidance | | Phenylephrine / norepinephrine | Alpha agonist (rescue) | No adverse interaction | First-line vasopressor choice |